Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.
Clinical trial NCT00102128 · TERMINATED
Trial details
- NCT number
- NCT00102128
- Sponsor
- Genzyme, a Sanofi Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Primary completion
- 2007-04-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.